Hastaya Covid 19 tanısı konulması
Aktif kanama veya açıklanamayan hematokrit düşüklüğü veya trombosit sayısı <30.000/µl
Evet Hayır
Dr. Mert İlker Hayıroglu
Dr. Tufan Çınar

Referanslar: 1- Çınar T, Hayıroğlu Mİ, Çiçek V, Uzun M, Orhan AL. COVID-19 and acute myocarditis: current literature review and diagnostic challenges. Rev Assoc Med Bras (1992). 2020 ;66Suppl 2(Suppl 2):48-54.
2- Piccioni A, Brigida M, Loria V, Zanza C, Longhitano Y, Zaccaria R, Racco S, Gasbarrini A, Ojetti V, Franceschi F, Candelli M. Role of troponin in COVID-19 pandemic: a review of literature. Eur Rev Med Pharmacol Sci. 2020;24(19):10293-10300
3- Buja LM, Wolf DA, Zhao B, Akkanti B, McDonald M, Lelenwa L, Reilly N, Ottaviani G, Elghetany MT, Trujillo DO, Aisenberg GM, Madjid M, Kar B. The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): Report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities. Cardiovasc Pathol. 2020;48:107233.
4- Veronese G, Ammirati E, Chen C, Klingel K, Suzuki M, Okumura T, Maisch B, Zuo H, Ni L, Jiang J, Zhang J, Wang H, Zhou N, Tschope C, Cooper LT, Wang DW. Management perspectives from the 2019 Wuhan international workshop on fulminant myocarditis. Int J Cardiol. 2020:S0167-5273(20)34050-X.
5- Hu H, Ma F, Wei X, Fang Y. Coronavirus fulminant myocarditis saved with gluco- corticoid and human immunoglobulin. Eur Heart J 2020;41:doi:10.1093/eurheartj/ehaa190.
6- Zeng JH, Liu YX; Yuan J, Wang FX, Wu WB, Li JX, Wang LF, Gao H, Wang Y, Dong CF, Li YJ, Xie XJ, Feng C, Liu L. First case of COVID-19 complicated with fulminant myocarditis: a case report and insights. Infection 2020;doi: org/10.1007/s15010-020-01424-5.
7- Zheng Y-Y, Ma Y-T, Zhang J-Y, Xie X. COVID-19 and the cardiovascular system. Nature Rev Cardiol 2020;17:259–260.
8- Basso C, Leone O, Rizzo S, De Gaspari M, van der Wal AC, Aubry MC, Bois MC, Lin PT, Maleszewski JJ, Stone JR. Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study. Eur Heart J. 2020;41(39):3827-3835.

OAK, oral antikoagülan;
NOAK, yeni antikoagülanlar;
GFR, Glomerüler filtrasyon hızı;
DVT, derin ven trombozu;
PTE, pulmoner tromboemboli;
DMAH, düşük molekül ağırlıklı heparin;
EKG, elektrokardiyografi;
UFH, unfraksiyone heparin;
VKİ, vücut kitle indeksi.